Publikationen von M. Reschke

Reschke, M.; Ferby, I.; Stepniak, E.; Seitzer, N.; Horst, D.; Wagner, E. F.; Ullrich, A.: Mitogen-Inducible Gene-6 is a Negative Regulator of Epidermal Growth Factor Receptor Signaling in Hepatocytes and Human Hepatocellular Carcinoma. Hepatology 51 (4), S. 1383 - 1390 (2010)

Descot, A.; Hoffmann, R.; Shaposhnikov, D.; Reschke, M.; Ullrich, A.; Posern, G.: Negative Regulation of the EGFR-MAPK Cascade by Actin-MAL-Mediated Mig6/Errfi-1 Induction. Molecular Cell 35 (3), S. 291 - 304 (2009)

Reschke, M.; Mihic-Probst, D.; van der Horst, E. H.; Knyazev, P.; Wild, P. J.; Hutterer, M.; Meyer, S.; Dummer, R.; Moch, H.; Ullrich, A.: HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research 14 (16), S. 5188 - 5197 (2008)

Hutterer, M.; Knyazev, P.; Abate, A.; Reschke, M.; Maier, H.; Stefanova, N.; Knyazeva, T.; Barbieri, V.; Reindl, M.; Muigg, A. et al.; Kostron, H.; Stockhammer, G.; Ullrich, A.: Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clinical Cancer Research 14 (1), S. 130 - 138 (2008)

Ferby, I.; Reschke, M.; Kudlacek, O.; Knyazev, P.; Pante, G.; Amann, K.; Sommergruber, W.; Kraut, N.; Ullrich, A.; Fässler, R. et al.; Klein, R.: Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nature Medicine 12 (5), S. 568 - 573 (2006)

Reschke, M.: Mitogen-Inducible Gene-6 is a Negative Regulator of the HER-family of Receptor Tyrosine Kinases. Dissertation, Technische Universität, München (2008)